Crispr Therapeutics call volume above normal and directionally bullish
The Fly

Crispr Therapeutics call volume above normal and directionally bullish

Bullish option flow detected in Crispr Therapeutics with 1,861 calls trading, 1.2x expected, and implied vol increasing over 1 point to 53.61%. Jan-25 50 calls and Sep-24 40 puts are the most active options, with total volume in those strikes near 470 contracts. The Put/Call Ratio is 0.28. Earnings are expected on November 4th.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App